Navigation Links
UB Neurosurgery Awarded Full Accreditation For Doppler Testing Of Carotid Artery Disease
Date:5/15/2010

Early detection of vascular disease by an accredited testing site provides doctors the essential information they need to properly manage the condition and prevent future stroke.

(Vocus) May 15, 2010 -- University at Buffalo Neurosurgery (UBNS) has been awarded full accreditation by the Intersocietal Commission for the Accreditation of Vascular Laboratories (ICAVL) for demonstrating excellence in patient care and commitment to vascular disease testing of the highest quality.

UBNS began in-house testing for vascular disease in August 2008 when it acquired a carotid Doppler machine to save patients the inconvenience of having to travel elsewhere for their imaging studies. Carotid Doppler is a safe, painless, and noninvasive ultrasound test used to monitor blood flow from the carotid arteries to the brain. Doppler images help physicians determine whether blood flow to the brain has been compromised by narrowed blood vessels due to plaque buildup. Evidence of extensive carotid narrowing may lead to a diagnosis of carotid artery disease (CAD)—a major risk factor for stroke.

Stroke, the third leading cause of death in the United States, occurs as a result of CAD when blood clots or dislodged plaque block the narrowed carotid artery, thereby interrupting blood flow to the brain. Carotid Doppler can detect CAD before a stroke occurs, giving doctors and patients the opportunity to determine if measures should be taken to prevent future stroke. If indicated, patients may undergo a minimally invasive carotid stenting procedure to widen the blocked artery and capture any dislodged plaque.

During the accreditation process, UBNS’ Doppler clinic was subjected to intense scrutiny of its protocol and quality assurance practices and evaluated for its overall impact on the quality of patient health. The clinic’s full accreditation status is a testament to its consistent delivery of outstanding patient care.

The ICAVL is a non-profit organization established with the support of eleven medical societies including physicians, technologists, and sonographers that represent medical specialties including cardiology, neurology, radiology, vascular medicine, vascular surgery, neurosurgery, internal medicine, and biology.    

About UBNS

University at Buffalo Neurosurgery (UBNS) is an academic neurosurgical group and leading regional referral center for cerebrovascular disorders run by a distinguished team of neurosurgical specialists and subspecialists committed to superior patient care, resident education, and translational research. UBNS diagnoses and treats a wide range of conditions, including but not limited to aneurysms; stroke; back and neck pain; epilepsy; Parkinson’s disease; hydrocephalus; and tumors of the brain, spine, and skull base. It is also the only neurosurgical group in Western New York with FDA approval to conduct device-related clinical trials for acute stroke. Visit www.ubns.com for more information.

###

Read the full story at http://www.prweb.com/releases/2010/05/prweb4007154.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related medicine news :

1. Grubb & Ellis Healthcare REIT II Enters Agreement to Acquire the Center for Neurosurgery and Spine Near St. Cloud, Minn.
2. Lumenis Inc. Awarded a 3-year Dual Source Agreement with Novation
3. MU awarded $8.5 million to explore tiny vessels role in cardiovascular diseases
4. Therapure Awarded $4.2 Million BIP Grant from the Ontario Government
5. LA BioMed awarded research grant to study HIV prevention gel
6. £3M awarded for climate model to predict disease outbreak
7. Onyx M.D. Awarded GSA Schedule Contract Creating Increases Access to Government Physician Jobs
8. OHSU awarded $5.8 million to expand health information technology education
9. SWOG cancer trials network awarded over $120 million in NCI grants
10. Semel Institute awarded $15M to establish new integrative phenotyping center
11. Canadian research team awarded international grant for work on Indigenous peoples health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... Beach, CA (PRWEB) , ... June 25, 2016 , ... ... UCLA with Magna Cum Laude and his M.D from the David Geffen School of ... Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from PsychTests.com reveals that ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell ... pain and the benefits of holistic treatments, Serenity Recovery Center of Marne, ... Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood ...
(Date:6/24/2016)... MIAMI, Fla. (PRWEB) , ... June 24, 2016 , ... ... Florida Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this ... of Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this ...
(Date:6/24/2016)... ... ... BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a ... an hour by 2020 and then adjusting it yearly to increase at the same rate ... assure the wage floor does not erode again, and make future increases more predictable. , ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Dialysis Devices Global Market - Forecast to 2022" report ... is the treatment method for the patients with kidney failure, ... and excess fluid from the patient,s blood and thus the ... sodium, potassium and chloride in balance. Increasing ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
Breaking Medicine Technology: